Fanghang Zhou

Title: Fanghang Zhou: Innovator in Viral Infection Treatment

Introduction

Fanghang Zhou is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes PIM1 inhibitors.

Latest Patents

Fanghang Zhou holds a patent for "PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof." This patent describes a PIM-1 proto-oncogene, serine/threonine kinase (PIM1) inhibitor that is effective in treating viral infections. The method involves administering an effective antiviral amount of a PIM1 inhibitor to a human afflicted with a viral infection. Additionally, the patent outlines a pharmaceutical composition that includes a PIM1 inhibitor and a pharmaceutically acceptable excipient.

Career Highlights

Fanghang Zhou is affiliated with the City University of Hong Kong, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating viral infections, showcasing his dedication to advancing healthcare.

Collaborations

Fanghang Zhou has collaborated with notable colleagues, including Ming-Liang He and Ying Chen. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Fanghang Zhou's contributions to the field of viral infection treatment through his innovative use of PIM1 inhibitors highlight his role as a leading inventor. His work not only advances medical science but also offers hope for effective treatments against viral infections.